TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.